Search Results - "宮良, 高維"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    アミロイドーシスを合併した成人型Still病の1剖検例 by 山里, 代利子, 兼島, 洋, 新垣, 紀子, 屋良, さとみ, 宮良, 高維, 比嘉, 太, 斎藤, 厚, 戸田, 隆義

    Published in 日本内科学会雑誌 (10-01-2000)
    “…症例は34歳,女性. 1984年第一子を出産後に成人型Still病を発症.以後プレドニゾロン20~30mg/日投与されていた. 1997年1月カリニ肺炎で入院. ST合剤投与し症状改善.経過中感染症を繰り返したが治療に反応し軽快していた…”
    Get full text
    Journal Article
  3. 3

    結核により悪性リンパ腫様の縦隔並びに肺門リンパ節腫脹を来したAIDSの1例 by 宮良, 高維, 仲本, 敦, 比嘉, 太, 健山, 正男, 斎藤, 厚

    Published in 日本内科学会雑誌 (1997)
    “…症例はタイより帰国した48歳の男性.現地でAIDSと診断された.当科初診時の末梢血CD4リンパ球数は17/μlであった…”
    Get full text
    Journal Article
  4. 4

    Legionella実験肺炎モデルにおけるrG-CSF, ceftazidimeの併用効果 by 宮良, 高維

    Published in CHEMOTHERAPY (1993)
    “…Recombinannt human granulocyte-colony stimulating factor (rG-CSF) のLegionella感染実験肺炎に対する効果を検討した。亜致死量 (1×104CFU/body) のレジオネラを感染せしめたモルモットの循環血中の好中球数は増加し,…”
    Get full text
    Journal Article
  5. 5

    キノロン系抗菌剤levofloxacinのヒト好中球内への移行に関する検討 by 我謝, 道弘, 比嘉, 太, 山城, 哲, 仲本, 敦, 宮良, 高維, 新里, 敬, 普久原, 浩, 橘川, 桂三, 伊良部, 勇栄, 重野, 芳輝, 斎藤, 厚

    Published in CHEMOTHERAPY (1992)
    “…キノロン系抗菌剤levofloxacin (LVFX, DR有3355) は, ofloxacin (OFLX) の一方の光学活性S-(-) 体であり, その抗菌力はOFLXのほぼ2倍である。LVFXおよびその他方の光学活性R-(+) 体であるDR-3354ならびにOFLXのヒト好中球細胞内移行性につき比較検討した。…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Sustained Improvements in Antimicrobial Therapy and Clinical Outcomes following a Pharmacist-Led Antimicrobial Stewardship Intervention: Uncontrolled Before-After Study by Uda, Atsushi, Ebisawa, Kei, Sakon, Hitomi, Kusuki, Mari, Izuta, Rie, Yahata, Mariko, Yano, Ikuko, Miyara, Takayuki

    Published in Journal of clinical medicine (01-02-2022)
    “…Our antimicrobial pharmacist-led intervention included: (a) a structured review of antibiotic prescriptions; (b) educating prescribers on antimicrobial…”
    Get full text
    Journal Article
  8. 8

    Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing Escherichia coli with ST131- fimH30 in a City Hospital in Hyogo, Japan by Teramae, Masazumi, Osawa, Kayo, Shigemura, Katsumi, Kitagawa, Koichi, Shirakawa, Toshiro, Fujisawa, Masato, Miyara, Takayuki

    “…Extended-spectrum β-lactamase (ESBL)-producing isolates are known to tolerate superior quinolone antimicrobials compared with other antibacterial agents. Among…”
    Get full text
    Journal Article
  9. 9

    Effect of educational intervention on the appropriate use of oral antimicrobials in oral and maxillofacial surgery: a retrospective secondary data analysis by Kusumoto, Junya, Uda, Atsushi, Kimura, Takeshi, Furudoi, Shungo, Yoshii, Ryosuke, Matsumura, Megumi, Miyara, Takayuki, Akashi, Masaya

    Published in BMC oral health (07-01-2021)
    “…In Japan, oral third-generation cephalosporins with broad-spectrum activity are commonly prescribed in the practices of dentistry and oral surgery. However,…”
    Get full text
    Journal Article
  10. 10

    Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins by Uda, Atsushi, Kimura, Takeshi, Nishimura, Sho, Ebisawa, Kei, Ohji, Goh, Kusuki, Mari, Yahata, Mariko, Izuta, Rie, Sakaue, Tomoyuki, Nakamura, Tatsuya, Koike, Chihiro, Tokimatsu, Issei, Yano, Ikuko, Iwata, Kentaro, Miyara, Takayuki

    Published in Infection (01-12-2019)
    “…Purpose This study aimed to evaluate the efficacy of an educational intervention on reducing the inappropriate use of oral third-generation cephalosporins, the…”
    Get full text
    Journal Article
  11. 11

    Antibiotic de-escalation therapy in patients with community-acquired nonbacteremic pneumococcal pneumonia by Uda, Atsushi, Tokimatsu, Issei, Koike, Chihiro, Osawa, Kayo, Shigemura, Katsumi, Kimura, Takeshi, Miyara, Takayuki, Yano, Ikuko

    Published in International journal of clinical pharmacy (01-12-2019)
    “…Background De-escalation therapy is recommended as an effective antibiotic treatment strategy for several infectious diseases. While there is limited evidence…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital by Uda, Atsushi, Onuma, Kenichiro, Shigemura, Katsumi, Kitagawa, Koichi, Yan, Yonmin, Osawa, Kayo, Yano, Ikuko, Miyara, Takayuki

    Published in Antibiotics (Basel) (14-10-2021)
    “…Cefazolin is an essential antibiotic used for treating bacteremia; in particular, it is recommended as a first-line agent for infections caused by…”
    Get full text
    Journal Article
  14. 14

    The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing Escherichia coli by Onishi, Reo, Shigemura, Katsumi, Osawa, Kayo, Yang, Young-Min, Maeda, Koki, Fang, Shiuh-Bin, Sung, Shian-Ying, Onuma, Kenichiro, Uda, Atsushi, Miyara, Takayuki, Fujisawa, Masato

    Published in Antibiotics (Basel) (28-12-2021)
    “…Imipenemase-6 (IMP-6) type carbapenemase-producing is regarded as dangerous due to its unique lack of antimicrobial susceptibility. It is resistant to…”
    Get full text
    Journal Article
  15. 15

    PENETRATION OF LEVOFLOXACIN, A NEW QUINOLONE ANTIBACTERIAL AGENT, INTO HUMAN NEUTROPHILS by Gaja, Michihiro, Higa, Futoshi, Yamashiro, Tetsu, Nakamoto, Atsushi, Miyara, Takayuki, Shinzato, Takashi, Fukuhara, Hiroshi, Kitsukawa, Keizou, Irabu, Yuei, Shigeno, Yoshiteru, Saito, Atsushi

    Published in CHEMOTHERAPY (25-05-1992)
    “…Levofloxacin (LVFX, DR-3355), a new quinolone antibacterial agent, is the S-(-) isomer of ofloxacin (OFLX). The antibacterial activity of LVFX is twice as…”
    Get full text
    Journal Article
  16. 16

    How Does Antimicrobial Stewardship Affect Inappropriate Antibiotic Therapy in Urological Patients? by Uda, Atsushi, Shigemura, Katsumi, Kitagawa, Koichi, Osawa, Kayo, Onuma, Kenichiro, Inoue, Shigeaki, Kotani, Joji, Yan, Yonmin, Nakano, Yuzo, Nishioka, Tatsuya, Yano, Ikuko, Miyara, Takayuki, Fujisawa, Masato

    Published in Antibiotics (Basel) (06-02-2020)
    “…Antimicrobial stewardship teams (ASTs) have been well-accepted in recent years; however, their clinical outcomes have not been fully investigated in urological…”
    Get full text
    Journal Article
  17. 17

    A case of pulmonary infection caused by Mycobacterium szulgai by Haranaga, Shusaku, Sato, Yoko, Tohyama, Masaki, Toyama, Masato, Ishimine, Tomohiko, Miyara, Takayuki, Shinzato, Takashi, Higa, Futoshi, Tateyama, Masao, Saito, Atsushi

    Published in Kekkaku (01-05-2002)
    “…We report a case of pulmonary non-tuberculous mycobacteriosis caused by Mycobacterium szulgai. A thirty-nine-year-old man with no relevant significant past…”
    Get more information
    Journal Article
  18. 18

    Synergistic effect of recombinant human granulocyte-colony stimulating factor (rG-CSF) and ceftazidime in the treatment of experimental Legionella pneumonia in guinea pigs by Miyara, Takayuki

    Published in CHEMOTHERAPY (1993)
    “…We investigated the antimicrobial chemotherapy-enhancing effects of recombinant human granulocyte-colony stimulating factor (rG-CSF) in treating experimental…”
    Get full text
    Journal Article